Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Marafini

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Expert Opinion on Biological Therapy|July 24, 2025
Advanced therapies targeting IL-23: clinical outcomes in ulcerative colitisSilvia Salvatori, Irene Marafini, Antonio Fonsi, et al.
Digestive Diseases (Basel, Switzerland)|September 15, 2015
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in ManIrene Marafini, Erika Angelucci, Francesco Pallone, et al.
Expert Opinion on Biological Therapy|August 3, 2019
Inflammatory cytokines: from discoveries to therapies in IBDIrene Marafini, Silvia Sedda, Vincenzo Dinallo, et al.
Inflammatory Bowel Diseases|September 13, 2014
Targeting integrins and adhesion molecules to combat inflammatory bowel diseaseIrene Marafini, Silvia Sedda, Francesco Pallone, et al.
International Reviews of Immunology|September 18, 2013
Th17 cytokines in inflammatory bowel diseases: discerning the good from the badEdoardo Troncone, Irene Marafini, Francesco Pallone, et al.
International Journal of Molecular Sciences|April 27, 2024
Aryl Hydrocarbon Receptor Signalling in the Control of Gut InflammationIrene Marafini, Ivan Monteleone, Federica Laudisi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 28, 2018
Oligonucleotide-Based Therapies for Inflammatory Bowel DiseaseGerolamo Bevivino, Silvia Sedda, Irene Marafini, et al.
Pharmacological Research|March 21, 2020
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseasesIrene Marafini, Edoardo Troncone, Silvia Salvatori, et al.
Biomedicines|January 28, 2026
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized TherapyIrene Marafini, Silvia Salvatori, Antonio Fonsi, et al.
Frontiers in Immunology|November 6, 2025
Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseasesGiovanni Monteleone, Carlo Calisi, Silvia Salvatori, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Expert Opinion on Biological Therapy|July 24, 2025
Advanced therapies targeting IL-23: clinical outcomes in ulcerative colitisSilvia Salvatori, Irene Marafini, Antonio Fonsi, et al.
Digestive Diseases (Basel, Switzerland)|September 15, 2015
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in ManIrene Marafini, Erika Angelucci, Francesco Pallone, et al.
Expert Opinion on Biological Therapy|August 3, 2019
Inflammatory cytokines: from discoveries to therapies in IBDIrene Marafini, Silvia Sedda, Vincenzo Dinallo, et al.
Inflammatory Bowel Diseases|September 13, 2014
Targeting integrins and adhesion molecules to combat inflammatory bowel diseaseIrene Marafini, Silvia Sedda, Francesco Pallone, et al.
International Reviews of Immunology|September 18, 2013
Th17 cytokines in inflammatory bowel diseases: discerning the good from the badEdoardo Troncone, Irene Marafini, Francesco Pallone, et al.
International Journal of Molecular Sciences|April 27, 2024
Aryl Hydrocarbon Receptor Signalling in the Control of Gut InflammationIrene Marafini, Ivan Monteleone, Federica Laudisi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 28, 2018
Oligonucleotide-Based Therapies for Inflammatory Bowel DiseaseGerolamo Bevivino, Silvia Sedda, Irene Marafini, et al.
Pharmacological Research|March 21, 2020
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseasesIrene Marafini, Edoardo Troncone, Silvia Salvatori, et al.
Biomedicines|January 28, 2026
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized TherapyIrene Marafini, Silvia Salvatori, Antonio Fonsi, et al.
Frontiers in Immunology|November 6, 2025
Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseasesGiovanni Monteleone, Carlo Calisi, Silvia Salvatori, et al.
Pageof 11